Publicaciones
-
Ramírez MJ, Pujol R, Minguillón J, Bogliolo M, Persico I, Cavero D, de la Cal A, Río P, Navarro S, Casado JA, Bailador A, de la Fuente AS, de Heredia ML, Almazán F, Antelo ML, Argilés B, Badell I, Baragaño M, Beléndez C, Bermúdez M, Bernués M, Buedo MI, Carrasco E, Català-Temprano A, Costa D, Cuesta I, Fernandez-Delgado R, Fernández-Teijeiro A, Figuera Á, García M, Gondra A, González M, Muñiz SG, Hernández-Rodríguez I, Ibañez F, Kelleher NJ, Lendínez F, López M, López-Almaraz R, Marchante I, Mendoza C, Nieto J, Ojeda E, Payán-Pernía S, Peláez I, de Soto IP, Portugal R, Ramos-Arroyo MA, Regueiro A, Rodríguez A, Rosell J, Saez R, Sánchez J, Sánchez M, Senent M, Tapia M, Trujillo-Quintero JP, Vagace JM, Verdú-Amorós J, Verdugo V, Vidales I, Villarreal J, Díaz-de-Heredia C, Sevilla J, Bueren JA and Surrallés J.
Prognostic significance of mutation type and chromosome fragility in Fanconi anemia
AMERICAN JOURNAL OF HEMATOLOGY . 100(2): 272-284. Nº de citas: 1
-
Romero-Moya D, Pera J, Marin-Bejar O, Torralba-Sales E, Murillo-Sanjuán L, Diaz-de-Heredia C, Montoro J, Rodríguez-Ubreva J, Liquori A, Cervera J, Wlodarski MW, Català-Temprano A and Giorgetti A.
Multiple phenotypes and epigenetic profiles in a three-generation family history with GATA2 deficiency
Leukemia . : .
-
Quintillá-Martínez JM, de la Gala C, Berrueco R, Claverol J, Figueres B, Bergós A, Rodríguez L, Mora A, DiBiaso V, Llanos C and Nafria-Escalera B.
High-Fidelity Clinical Simulation to Improve a Pediatric Clinical Trial Design: Lessons Learned and Conceptualization of the Return on Investment (ROI) and Return on Engagement (ROE) Analysis
PEDIATRIC DRUGS . 27(1): 73-84.
-
Guerrero-Murillo M, Rill-Hinarejos A, Trincado JL, Bataller A, Ortiz-Maldonado V, Benítez-Ribas D, Español-Rego M, González-Navarro EA, Martínez-Cibrián N, Marchese D, Martín-Martín L, Martín García-Sancho A, Rives-Solà S, Heyn H, Juan M, Urbano-Ispizúa Á, Delgado J, Orfao A, Mereu E, Bueno C and Menendez P.
Integrative single-cell multi-omics of CD19-CARpos and CARneg T cells suggest drivers of immunotherapy response in B cell neoplasias
CELL REPORTS MEDICINE . 5(11): 101803-101803. Nº de citas: 1
-
Mesegue-Meda M.
Guía de medicamentos a base de plantas para el tratamiento del resfriadocomún en pediatría
Revista de Fitoterapia . 20(2): 139-151.
-
Theron A, Alonso-Saladrigues A, Dapena JL, López-Duarte M, Diaz de Heredia C, Verdú-Amorós J, Sarrate E, Esperanza-Cebollada E, Cuatrecasas E, Andreu S, Conde N, Sanchez-Sierra N, Isola I, Camós-Guijosa M, Torrebadell-Burriel M, Rives-Solà S and Català-Temprano A.
Secondary haematological dysplasia after CAR-T-cell therapy for acute lymphoblastic leukaemia in children
BRITISH JOURNAL OF HAEMATOLOGY . : 186-194.
-
Bohlen J, Bagaric I, Vatovec T, Ogishi M, Ahmed SF, Cederholm A, Buetow L, Sobrino S, Le Floc'h C, Arango-Franco CA, Seabra L, Michelet M, Barzaghi F, Leardini D, Saettini F, Vendemini F, Baccelli F, Català-Temprano A, Gambineri E, Veltroni M, Aguilar de la Red Y, Rice GI, Consonni F, Berteloot L, Largeaud L, Conti F, Roullion C, Masson C, Bessot B, Seeleuthner Y, Le Voyer T, Rinchai D, Rosain J, Neehus AL, Erazo-Borrás L, Li H, Janda Z, Cho EJ, Muratore E, Soudée C, Lainé C, Delabesse E, Goulvestre C, Ma CS, Puel A, Tangye SG, André I, Bole-Feysot C, Abel L, Erlacher M, Zhang SY, Béziat V, Lagresle-Peyrou C, Six E, Pasquet M, Alsina L, Aiuti A, Zhang P, Crow YJ, Landegren N, Masetti R, Huang DT, Casanova JL and Bustamante J.
Autoinflammation in patients with leukocytic CBL loss of heterozygosity is caused by constitutive ERIC-mediated monocyte activation
JOURNAL OF CLINICAL INVESTIGATION . 134(20): .
-
Mato S, Castrejón-de-Anta N, Colmenero A, Carità L, Salmerón-Villalobos J, Ramis-Zaldivar JE, Nadeu F, Garcia N, Wang L, Verdú-Amorós J, Andrés M, Conde N, Celis-Passini V, Ortega MJ, Galera A, Astigarraga I, Perez-Alonso V, Quiroga E, Jiang A, Scott DW, Campo E, Balagué O and Salaverria I.
MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma
BLOOD CANCER JOURNAL . 14(1): 171-171. Nº de citas: 1
-
González de Aledo-Castillo JM, Argudo-Ramírez A, Beneitez-Pastor D, Collado-Gimbert A, Almazán Castro F, Roig-Bosch S, Andrés-Masó A, Ruiz-Llobet A, Pedrals-Portabella G, Medina-Santamaria D, Nadal-Rey G, Espigares-Salvia M, Coll-Sibina MT, Algar-Serrano M, Torrent-Español M, Leoz-Allegretti P, Rodríguez-Pebé A, García-Bernal M, Solà-Segura E, García-Gallego A, Prats-Viedma B, López-Galera RM, Paredes-Fuentes AJ, Pajares García S, Delgado-López G, Blanco-Álvarez A, Tazón-Vega B, Díaz de Heredia C, Mañú-Pereira MDM, Marín-Soria JL, García-Villoria J, Velasco-Puyó P and On Behalf Of The Sickle Cell Disease Newborn Screening Group Of Catalonia.
Newborn Screening for Sickle Cell Disease in Catalonia between 2015 and 2022-Epidemiology and Impact on Clinical Events.
International Journal of Neonatal Screening . 10(4): .
-
Berrueco R, Nuria Caballero Mencía, López-Tierling M, Benedicto C, Cristina González-Anleo López, Rodríguez-Nieva N, David Nadal Miquel, Vinyets J and Jabalera M.
Mapping the Patient Experience in a Pediatric Hemophilia Unit: Our Patient Journey
Journal of Clinical Medicine . 13(20): . Nº de citas: 1